On 2026-10-12, Guggenheim raised its ELV price target to $460.
Guggenheim 于 2026-10-12 将 ELV 目标价上调至 $460。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
ELV earnings call: Operating cash flow totaled $1.3 billion in the quarter, and we are raising our full-year operating cash flow guidance to at least $6.5 billion.Elevance Health, Inc. (ELV) 电话会：本季度运营现金流总计13亿美元，我们将全年运营现金流指引上调至至少65亿美元。
Earnings Analysis · October 21, 2026财报电话会 · 2026/10/21
ELV earnings release — revenue reportedElevance Health, Inc. (ELV) 财报发布 — 营收 已公布
Earnings Release · October 21, 2026财报快讯 · 2026/10/21
Elevance Health Inc. (ELV) rises 5.02% to $416.81Elevance Health Inc.（ELV）上涨 5.02%，报 $416.81
Stock Price Move · September 10, 2026个股行情异动 · 2026/9/10
